×

Intellectual Property Patents

  • Allergan CEO Brent Saunders is interviewed on the floor of the New York Stock Exchange.

    The group is the latest to call on lawmakers to examine Allergan's controversial patent deal with a Native American tribe.

  • CEO of global pharamceutical company Allergan Brenton Saunders.

    Allergan's unusual deal to shield Restasis from patent challenges has drawn scrutiny from competitors, lawmakers and now a federal judge.

  • Patent Trial and Appeal Board said Neptune Generics LLC and other companies failed to show it was more likely than not that 22 claims underlying the Lilly patent could not be patented. Alimta is Lilly's third biggest-selling drug, accounting for $2.28 billion of the Indianapolis- based company's $21.22 billion of revenue last year, a regulatory filing shows.

  • The ruling from the U.S. Court of Appeals for the Federal Circuit in Washington was a setback for Amgen Inc, which claimed Praluent infringed patents on its rival drug, Repatha, and had won the sales ban after a jury trial. Regeneron shares jumped 4.4 percent to $475.95 on the Nasdaq, while Sanofi shares in Paris rose 0.8 percent. Amgen shares were off 1.5 percent at...

  • Allergan's unusual patent agreement

    CNBC's Meg Tirrell reports on senators commenting on Allergan's patent agreement with the Saint Regis Mohawk Tribe.

  • Allergan's Restasis medicine for dry eyes.

    Allergan is urging the Senate Judiciary Committee to review the patent challenge system it’s been accused of thwarting.

  • The Allergan post at the New York Stock Exchange.

    Senator Claire McCaskill late Monday called Allergan's deal a "brazen loophole" she says should be illegal.

  • TORONTO, Oct 2- The man who was leading BlackBerry Ltd's efforts to make money from its patent portfolio has left to join a health technology company, two sources with knowledge of the move said on Monday. Mark Kokes left the Canadian company last month to join privately held NantWorks LLC, the sources said. NantWorks was founded in 2011 by billionaire Patrick...

  • BRUSSELS, Oct 2- The European Union is drawing up guidelines on how much patent holders should charge for their technologies, a thorny issue that pits Apple and other users against Qualcomm and Ericsson. The patent fee model used by world No. 1 smartphone chip designer Qualcomm predominates in the tech industry and is based on how much value a technology adds to a...

  • BRUSSELS, Oct 2- The European Union is drawing up guidelines on how much patent holders should charge for their technologies, a thorny issue that pits Apple and other users against Qualcomm and Ericsson. The patent fee model used by world No. 1 smartphone chip designer Qualcomm, which bases royalties on a product's total cost, predominates in the tech industry but...

  • WASHINGTON, Sept 27- The U.S. International Trade Commission has agreed to probe certain Wi-Fi enabled devices and their parts after Japan's Sharp Corp accused China's Hisense Group Co Ltd of infringing its patents, the body said on Wednesday. Sharp, which had licensed Hisense to use the brand to sell televisions in the United States, sued the Chinese...

  • Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds that the board has no jurisdiction over the tribe. In its court filing on Friday, the tribe said it is sovereign government that cannot face litigation in an administrative court...

  • Sept 22- A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents. Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds...

  • ST REGIS MOHAWK TRIBE MOVES TO DISMISS MYLAN CHALLENGE TO ALLERGAN PATENTS- FILING.

  • TRIBE SAYS ITS SOVEREIGN STATUS IMMUNIZES RESTASIS PATENTS FROM U.S.

  • HELSINKI, Sept 18- Nokia will start to book additional revenue from the current quarter after a ruling by an arbitration court on payments from South Korea's LG Electronics for using its smartphone patents. We continue to see potential for additional licensing opportunities, "said Nokia Chief Legal Officer Maria Varsellona in a statement.

  • The Ohio Democrat said he will look at how Congress can "close loopholes that drug companies exploit to avoid competition. Allergan said it has reached out to Brown's office "to provide the facts and context around this agreement with the Saint Regis Mohawk Tribe." Allergan said on Sept. 8 it will transfer patents relating to its dry-eye medicine Restasis to the...

  • The Ohio Democrat said he will look at how Congress can "close loopholes that drug companies exploit to avoid competition. Allergan said it has reached out to Brown's office "to provide the facts and context around this agreement with the Saint Regis Mohawk Tribe." Allergan said on Sept. 8 it will transfer patents relating to its dry-eye medicine Restasis to the...

  • Reddy's, Allergan Plc's Actavis Laboratories, Endo International's Par Pharmaceutical, Alvogen Pharma US, Teva Pharmaceutical Industries and Mylan NV. The lawsuits allege that these companies have infringed a patent that relates to an oral film containing buprenorphine and naloxone, the key constituents of Suboxone, the London- listed drugmaker said in a...

  • Sept 13- As generic drug manufacturers are. Last week, Allergan announced it would transfer the patent rights to its Restasis dry-eye treatment to the Saint Regis Mohawk Tribe, which will license them back to the company in exchange for ongoing payments. But Richard Torczon, a lawyer for generic drug company Mylan.